October 09, 2012

Sanofi to Launch State-of-the Art, Reusable Insulin Pen AllStar™ in India

- Sanofi shows its continued commitment to patients’ needs in emerging markets and improves access to innovative, affordable devices –

 

Sanofi to Launch State-of-the Art, Reusable Insulin Pen AllStar™ in India
- Sanofi shows its continued commitment to patients’ needs in emerging markets and improves access to innovative, affordable devices –

Paris, France – October 9, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the launch by Sanofi India Limited of AllStar™, the first Indian-manufactured, re-usable insulin pen, manufactured by a global company in India. Developed especially for patients in emerging markets, AllStar™ is indicated for use of insulinized patients using Sanofi’s insulin portfolio, and also for insulin-naive patients who are starting to use insulin. The AllStar™ re-usable insulin pen conforms to ISO (International Organization for Standardization) standards and is equipped with state-of-theart features.